Providing plant-based ingredients and pharmaceutical excipients. Developing solutions for cell culture and protein stabilization.
A
CSR Analysis score
The organization is among the top 5% of organizations with the most committed CSR positioning, among comparable organizations.
+160,000
Total organizations analyzedAnalysis by axis
Access the detailed report with all sector benchmarks, in-depth competitive analysis and actionable recommendations.
Methodology: Score calculated according to 6 CSR themes (Carbon, Biodiversity, Circular Economy, Sustainable Investments, Governance, Social Impact)
Sources: Public data, CSR reports, documented initiatives, official databases
Last update: January 2026
This analysis is not yet available in English. Please see the French version.
Leading organizations
Weishardt
B
Production of gelatin, texturing solutions, and marine collagen peptides for the food, beverage, and pharmaceutical industries.
Seqens
A
Manufacturing of a broad range of ingredients for the pharmaceutical industry, including generic and custom APIs, intermediates, and excipients.
Delpharm
A
Development and manufacturing of pharmaceuticals for third parties, including sterile and non-sterile liquids, solids, semi-solids, and biotech forms.
Initiatives identified among leaders
Réduction de l'empreinte carbone et environnementale
“Seqens lance le projet Phoenix pour produire du pa...” - SeqensDéploiement de normes de sécurité et réduction des accidents du travail
“Delpharm a mis en place un programme de sécurité i...” - DelpharmRéduction de l'impact environnemental
“Weishardt | Naticol® prend des mesures concrètes p...” - Weishardt58% of similar organizations communicate on CSR issues
+1229 initiatives collected from 50 similar organizations
Is your score incomplete? Update your CSR information and improve your positioning.
Claim this page
Updated data
Personalized recommendations
Access complete data, competitive analyses and actionable recommendations for your clients.
Comprehensive sector benchmarks
Competitive data
Ready-to-use reports